LifeVantage Corporation will announce Q3 2025 financial results on May 6, followed by a conference call for investors.
Quiver AI Summary
LifeVantage Corporation, a prominent health and wellness company specializing in activating health processes at the cellular level, announced that it will release its financial results for the third quarter ended March 31, 2025, on May 6, 2025, after market close. Following the announcement, a conference call for investors will take place at 2:30 p.m. Mountain Time, with details on how to participate provided for both U.S. and international callers. A replay of the call will be accessible for two weeks after the event, and there will be a live webcast available on the company's Investor Relations website. LifeVantage, founded in 2003 and based in Lehi, Utah, offers a range of products aimed at improving health through nutrigenomics and features popular items like the Protandim® line and AXIO® energy drinks. For more information, details are available on their website.
Potential Positives
- Announcement of upcoming financial results demonstrates transparency and commitment to keeping investors informed.
- Scheduled investor conference call provides an opportunity for direct engagement with management, potentially increasing investor confidence.
- Company highlights its innovative product line, which may attract interest from health-conscious consumers and investors alike.
Potential Negatives
- Failure to provide specific financial expectations or guidance ahead of the earnings release could lead to uncertainty among investors, potentially affecting stock performance.
- The press release does not address any recent market challenges or competition in the health and wellness sector, which may raise concerns about the company's future positioning.
FAQ
What is the date of LifeVantage's upcoming financial results release?
LifeVantage will release its financial results on May 6, 2025, after the stock market closes.
What time is the investor conference call scheduled?
The investor conference call is scheduled for 2:30 p.m. Mountain Time on May 6, 2025.
How can investors participate in the conference call?
Investors can join by dialing (877) 704-4453 in the U.S. or (201) 389-0920 internationally.
Will there be a replay of the conference call available?
Yes, a replay will be available starting two hours after the call until May 20, 2025.
Where can I find more information about LifeVantage Corporation?
More information is available on the LifeVantage website at www.lifevantage.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LFVN Insider Trading Activity
$LFVN insiders have traded $LFVN stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $LFVN stock by insiders over the last 6 months:
- RAYMOND B GREER sold 8,000 shares for an estimated $161,221
- MICHAEL A BEINDORFF sold 5,850 shares for an estimated $114,309
- CYNTHIA LATHAM sold 4,450 shares for an estimated $89,089
- DARWIN LEWIS purchased 227 shares for an estimated $3,631
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LFVN Hedge Fund Activity
We have seen 37 institutional investors add shares of $LFVN stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LPL FINANCIAL LLC added 158,405 shares (+301.0%) to their portfolio in Q4 2024, for an estimated $2,776,839
- CAPITAL MANAGEMENT CORP /VA removed 118,345 shares (-28.2%) from their portfolio in Q4 2024, for an estimated $2,074,587
- ENVESTNET ASSET MANAGEMENT INC removed 76,629 shares (-34.4%) from their portfolio in Q4 2024, for an estimated $1,343,306
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 71,979 shares (+128.3%) to their portfolio in Q4 2024, for an estimated $1,261,791
- EAM INVESTORS, LLC added 60,243 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,056,059
- 683 CAPITAL MANAGEMENT, LLC added 49,500 shares (+inf%) to their portfolio in Q4 2024, for an estimated $867,735
- RENAISSANCE TECHNOLOGIES LLC removed 47,300 shares (-5.7%) from their portfolio in Q4 2024, for an estimated $829,169
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LFVN Analyst Ratings
Wall Street analysts have issued reports on $LFVN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Craig-Hallum issued a "Buy" rating on 01/14/2025
- Lake Street issued a "Buy" rating on 01/10/2025
To track analyst ratings and price targets for $LFVN, check out Quiver Quantitative's $LFVN forecast page.
$LFVN Price Targets
Multiple analysts have issued price targets for $LFVN recently. We have seen 2 analysts offer price targets for $LFVN in the last 6 months, with a median target of $32.5.
Here are some recent targets:
- Alex Fuhrman from Craig-Hallum set a target price of $35.0 on 01/14/2025
- Brooks O'Neil from Lake Street set a target price of $30.0 on 01/10/2025
Full Release
SALT LAKE CITY, April 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2025, after the stock market closes on Tuesday, May 6, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, May 20, 2025, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13752773, or (412) 317-6671 from international locations, and entering confirmation code 13752773.
There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1713783&tp_key=2ae12c0924 . The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com .
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
[email protected]
